In order to further prove the differentiation potential of AF cells and to establish their possible application in cell-based therapies for neurodegenerative diseases also their neuronal differentiation capacity was evaluated in the CD117+ as well as in CD117− and unselected cells. This evidence concerns the gene KIT and neurodegenerative disease.